47 related articles for article (PubMed ID: 26134187)
1. Opposing Responses of the Calcium Channel Blocker Nicardipine to Vascular Stiffness in the Elastic and Muscular Arteries in Rabbits.
Horikoshi Y; Katsuda SI; Fujikura Y; Hazama A; Shimura H; Shimizu T; Shirai K
J Atheroscler Thromb; 2021 Dec; 28(12):1340-1348. PubMed ID: 33746145
[TBL] [Abstract][Full Text] [Related]
2. Addition of a renin-angiotensin-aldosterone system inhibitor to a calcium channel blocker ameliorates arterial stiffness.
Kiuchi S; Hisatake S; Kawasaki M; Hirashima O; Kabuki T; Yamazaki J; Ikeda T
Clin Pharmacol; 2015; 7():97-102. PubMed ID: 26487804
[TBL] [Abstract][Full Text] [Related]
3. Immunological mechanisms of arterial damage in pediatric patients with primary hypertension.
Bujanowicz A; Skrzypczyk P
Cent Eur J Immunol; 2023; 48(2):150-157. PubMed ID: 37692028
[TBL] [Abstract][Full Text] [Related]
4. Nighttime home blood pressure lowering effect of esaxerenone in patients with uncontrolled nocturnal hypertension: the EARLY-NH study.
Kario K; Nishizawa M; Kato M; Ishii H; Uchiyama K; Nagai M; Takahashi N; Asakura T; Shiraiwa T; Yoshida T; Kaneshiro M; Taguchi T; Shiosakai K; Sugimoto K
Hypertens Res; 2023 Jul; 46(7):1782-1794. PubMed ID: 37173430
[TBL] [Abstract][Full Text] [Related]
5. Cardio-Vascular Interaction Evaluated by Speckle-Tracking Echocardiography and Cardio-Ankle Vascular Index in Hypertensive Patients.
Tabata T; Sato S; Ohno R; Iwakawa M; Kiyokawa H; Morinaga Y; Tanji N; Kinoshita T; Shimizu K
Int J Mol Sci; 2022 Nov; 23(22):. PubMed ID: 36430943
[TBL] [Abstract][Full Text] [Related]
6. New Horizons of Arterial Stiffness Developed Using Cardio-Ankle Vascular Index (CAVI).
Saiki A; Ohira M; Yamaguchi T; Nagayama D; Shimizu N; Shirai K; Tatsuno I
J Atheroscler Thromb; 2020 Aug; 27(8):732-748. PubMed ID: 32595186
[TBL] [Abstract][Full Text] [Related]
7. Potential Role of Antihypertensive Medications in Preventing Excessive Arterial Stiffening.
Jia G; Aroor AR; Martinez-Lemus LA; Sowers JR
Curr Hypertens Rep; 2018 Jul; 20(9):76. PubMed ID: 29980951
[TBL] [Abstract][Full Text] [Related]
8. Organ damage changes in patients with resistant hypertension randomized to renal denervation or spironolactone: The DENERVHTA (Denervación en Hipertensión Arterial) study.
Oliveras A; Armario P; Sans L; Clarà A; Vázquez S; Molina L; Pareja J; de la Sierra A; Pascual J
J Clin Hypertens (Greenwich); 2018 Jan; 20(1):69-75. PubMed ID: 29316186
[TBL] [Abstract][Full Text] [Related]
9. Inflammatory Markers for Arterial Stiffness in Cardiovascular Diseases.
Mozos I; Malainer C; Horbańczuk J; Gug C; Stoian D; Luca CT; Atanasov AG
Front Immunol; 2017; 8():1058. PubMed ID: 28912780
[TBL] [Abstract][Full Text] [Related]
10. Arterial stiffness in hematologic malignancies.
Mozos I; Borzak G; Caraba A; Mihaescu R
Onco Targets Ther; 2017; 10():1381-1388. PubMed ID: 28424554
[TBL] [Abstract][Full Text] [Related]
11. Should All Patients with Resistant Hypertension Receive Spironolactone?
Rosa J; Zelinka T; Petrák O; Štrauch B; Holaj R; Widimský J
Curr Hypertens Rep; 2016 Nov; 18(11):81. PubMed ID: 27787836
[TBL] [Abstract][Full Text] [Related]
12. Efficacy and safety of eplerenone in the management of mild to moderate arterial hypertension: systematic review and meta-analysis.
Pelliccia F; Patti G; Rosano G; Greco C; Gaudio C
Int J Cardiol; 2014 Nov; 177(1):219-28. PubMed ID: 25499383
[TBL] [Abstract][Full Text] [Related]
13. Effects of the selective aldosterone blocker eplerenone versus the calcium antagonist amlodipine in systolic hypertension.
White WB; Duprez D; St Hillaire R; Krause S; Roniker B; Kuse-Hamilton J; Weber MA
Hypertension; 2003 May; 41(5):1021-6. PubMed ID: 12682082
[TBL] [Abstract][Full Text] [Related]
14. Clinical effects of eplerenone, a selective aldosterone blocker, in Japanese patients with essential hypertension.
Sato A; Fukuda S
J Hum Hypertens; 2010 Jun; 24(6):387-94. PubMed ID: 19865106
[TBL] [Abstract][Full Text] [Related]
15. Eplerenone: a selective aldosterone receptor antagonist for hypertension and heart failure.
Moore TD; Nawarskas JJ; Anderson JR
Heart Dis; 2003; 5(5):354-63. PubMed ID: 14503934
[TBL] [Abstract][Full Text] [Related]
16. Effects of Add-on Therapy Consisting of a Selective Mineralocorticoid Receptor Blocker on Arterial Stiffness in Patients with Uncontrolled Hypertension.
Shibata T; Tsutsumi J; Hasegawa J; Sato N; Murashima E; Mori C; Hongo K; Yoshimura M
Intern Med; 2015; 54(13):1583-9. PubMed ID: 26134187
[TBL] [Abstract][Full Text] [Related]
17. Selective mineralocorticoid receptor blocker eplerenone reduces resistance artery stiffness in hypertensive patients.
Savoia C; Touyz RM; Amiri F; Schiffrin EL
Hypertension; 2008 Feb; 51(2):432-9. PubMed ID: 18195160
[TBL] [Abstract][Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
